Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Pharmacovigilance Market Size Analysis from 2022 to 2027
1.5.1 Global Pharmacovigilance Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Pharmacovigilance Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Pharmacovigilance Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Pharmacovigilance Industry Impact
Chapter 2 Global Pharmacovigilance Competition by Types, Applications, and Top Regions and Countries
2.1 Global Pharmacovigilance (Volume and Value) by Type
2.1.1 Global Pharmacovigilance Consumption and Market Share by Type (2016-2021)
2.1.2 Global Pharmacovigilance Revenue and Market Share by Type (2016-2021)
2.2 Global Pharmacovigilance (Volume and Value) by Application
2.2.1 Global Pharmacovigilance Consumption and Market Share by Application (2016-2021)
2.2.2 Global Pharmacovigilance Revenue and Market Share by Application (2016-2021)
2.3 Global Pharmacovigilance (Volume and Value) by Regions
2.3.1 Global Pharmacovigilance Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Pharmacovigilance Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Pharmacovigilance Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Pharmacovigilance Consumption by Regions (2016-2021)
4.2 North America Pharmacovigilance Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Pharmacovigilance Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Pharmacovigilance Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Pharmacovigilance Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Pharmacovigilance Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Pharmacovigilance Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Pharmacovigilance Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Pharmacovigilance Sales, Consumption, Export, Import (2016-2021)
4.10 South America Pharmacovigilance Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Pharmacovigilance Market Analysis
5.1 North America Pharmacovigilance Consumption and Value Analysis
5.1.1 North America Pharmacovigilance Market Under COVID-19
5.2 North America Pharmacovigilance Consumption Volume by Types
5.3 North America Pharmacovigilance Consumption Structure by Application
5.4 North America Pharmacovigilance Consumption by Top Countries
5.4.1 United States Pharmacovigilance Consumption Volume from 2016 to 2021
5.4.2 Canada Pharmacovigilance Consumption Volume from 2016 to 2021
5.4.3 Mexico Pharmacovigilance Consumption Volume from 2016 to 2021
Chapter 6 East Asia Pharmacovigilance Market Analysis
6.1 East Asia Pharmacovigilance Consumption and Value Analysis
6.1.1 East Asia Pharmacovigilance Market Under COVID-19
6.2 East Asia Pharmacovigilance Consumption Volume by Types
6.3 East Asia Pharmacovigilance Consumption Structure by Application
6.4 East Asia Pharmacovigilance Consumption by Top Countries
6.4.1 China Pharmacovigilance Consumption Volume from 2016 to 2021
6.4.2 Japan Pharmacovigilance Consumption Volume from 2016 to 2021
6.4.3 South Korea Pharmacovigilance Consumption Volume from 2016 to 2021
Chapter 7 Europe Pharmacovigilance Market Analysis
7.1 Europe Pharmacovigilance Consumption and Value Analysis
7.1.1 Europe Pharmacovigilance Market Under COVID-19
7.2 Europe Pharmacovigilance Consumption Volume by Types
7.3 Europe Pharmacovigilance Consumption Structure by Application
7.4 Europe Pharmacovigilance Consumption by Top Countries
7.4.1 Germany Pharmacovigilance Consumption Volume from 2016 to 2021
7.4.2 UK Pharmacovigilance Consumption Volume from 2016 to 2021
7.4.3 France Pharmacovigilance Consumption Volume from 2016 to 2021
7.4.4 Italy Pharmacovigilance Consumption Volume from 2016 to 2021
7.4.5 Russia Pharmacovigilance Consumption Volume from 2016 to 2021
7.4.6 Spain Pharmacovigilance Consumption Volume from 2016 to 2021
7.4.7 Netherlands Pharmacovigilance Consumption Volume from 2016 to 2021
7.4.8 Switzerland Pharmacovigilance Consumption Volume from 2016 to 2021
7.4.9 Poland Pharmacovigilance Consumption Volume from 2016 to 2021
Chapter 8 South Asia Pharmacovigilance Market Analysis
8.1 South Asia Pharmacovigilance Consumption and Value Analysis
8.1.1 South Asia Pharmacovigilance Market Under COVID-19
8.2 South Asia Pharmacovigilance Consumption Volume by Types
8.3 South Asia Pharmacovigilance Consumption Structure by Application
8.4 South Asia Pharmacovigilance Consumption by Top Countries
8.4.1 India Pharmacovigilance Consumption Volume from 2016 to 2021
8.4.2 Pakistan Pharmacovigilance Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Pharmacovigilance Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Pharmacovigilance Market Analysis
9.1 Southeast Asia Pharmacovigilance Consumption and Value Analysis
9.1.1 Southeast Asia Pharmacovigilance Market Under COVID-19
9.2 Southeast Asia Pharmacovigilance Consumption Volume by Types
9.3 Southeast Asia Pharmacovigilance Consumption Structure by Application
9.4 Southeast Asia Pharmacovigilance Consumption by Top Countries
9.4.1 Indonesia Pharmacovigilance Consumption Volume from 2016 to 2021
9.4.2 Thailand Pharmacovigilance Consumption Volume from 2016 to 2021
9.4.3 Singapore Pharmacovigilance Consumption Volume from 2016 to 2021
9.4.4 Malaysia Pharmacovigilance Consumption Volume from 2016 to 2021
9.4.5 Philippines Pharmacovigilance Consumption Volume from 2016 to 2021
9.4.6 Vietnam Pharmacovigilance Consumption Volume from 2016 to 2021
9.4.7 Myanmar Pharmacovigilance Consumption Volume from 2016 to 2021
Chapter 10 Middle East Pharmacovigilance Market Analysis
10.1 Middle East Pharmacovigilance Consumption and Value Analysis
10.1.1 Middle East Pharmacovigilance Market Under COVID-19
10.2 Middle East Pharmacovigilance Consumption Volume by Types
10.3 Middle East Pharmacovigilance Consumption Structure by Application
10.4 Middle East Pharmacovigilance Consumption by Top Countries
10.4.1 Turkey Pharmacovigilance Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Pharmacovigilance Consumption Volume from 2016 to 2021
10.4.3 Iran Pharmacovigilance Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Pharmacovigilance Consumption Volume from 2016 to 2021
10.4.5 Israel Pharmacovigilance Consumption Volume from 2016 to 2021
10.4.6 Iraq Pharmacovigilance Consumption Volume from 2016 to 2021
10.4.7 Qatar Pharmacovigilance Consumption Volume from 2016 to 2021
10.4.8 Kuwait Pharmacovigilance Consumption Volume from 2016 to 2021
10.4.9 Oman Pharmacovigilance Consumption Volume from 2016 to 2021
Chapter 11 Africa Pharmacovigilance Market Analysis
11.1 Africa Pharmacovigilance Consumption and Value Analysis
11.1.1 Africa Pharmacovigilance Market Under COVID-19
11.2 Africa Pharmacovigilance Consumption Volume by Types
11.3 Africa Pharmacovigilance Consumption Structure by Application
11.4 Africa Pharmacovigilance Consumption by Top Countries
11.4.1 Nigeria Pharmacovigilance Consumption Volume from 2016 to 2021
11.4.2 South Africa Pharmacovigilance Consumption Volume from 2016 to 2021
11.4.3 Egypt Pharmacovigilance Consumption Volume from 2016 to 2021
11.4.4 Algeria Pharmacovigilance Consumption Volume from 2016 to 2021
11.4.5 Morocco Pharmacovigilance Consumption Volume from 2016 to 2021
Chapter 12 Oceania Pharmacovigilance Market Analysis
12.1 Oceania Pharmacovigilance Consumption and Value Analysis
12.2 Oceania Pharmacovigilance Consumption Volume by Types
12.3 Oceania Pharmacovigilance Consumption Structure by Application
12.4 Oceania Pharmacovigilance Consumption by Top Countries
12.4.1 Australia Pharmacovigilance Consumption Volume from 2016 to 2021
12.4.2 New Zealand Pharmacovigilance Consumption Volume from 2016 to 2021
Chapter 13 South America Pharmacovigilance Market Analysis
13.1 South America Pharmacovigilance Consumption and Value Analysis
13.1.1 South America Pharmacovigilance Market Under COVID-19
13.2 South America Pharmacovigilance Consumption Volume by Types
13.3 South America Pharmacovigilance Consumption Structure by Application
13.4 South America Pharmacovigilance Consumption Volume by Major Countries
13.4.1 Brazil Pharmacovigilance Consumption Volume from 2016 to 2021
13.4.2 Argentina Pharmacovigilance Consumption Volume from 2016 to 2021
13.4.3 Columbia Pharmacovigilance Consumption Volume from 2016 to 2021
13.4.4 Chile Pharmacovigilance Consumption Volume from 2016 to 2021
13.4.5 Venezuela Pharmacovigilance Consumption Volume from 2016 to 2021
13.4.6 Peru Pharmacovigilance Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Pharmacovigilance Consumption Volume from 2016 to 2021
13.4.8 Ecuador Pharmacovigilance Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Pharmacovigilance Business
14.1 Eli Lilly and Company
14.1.1 Eli Lilly and Company Company Profile
14.1.2 Eli Lilly and Company Pharmacovigilance Product Specification
14.1.3 Eli Lilly and Company Pharmacovigilance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Clinquest Group B.V.
14.2.1 Clinquest Group B.V. Company Profile
14.2.2 Clinquest Group B.V. Pharmacovigilance Product Specification
14.2.3 Clinquest Group B.V. Pharmacovigilance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Chiltern
14.3.1 Chiltern Company Profile
14.3.2 Chiltern Pharmacovigilance Product Specification
14.3.3 Chiltern Pharmacovigilance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 ICON plc
14.4.1 ICON plc Company Profile
14.4.2 ICON plc Pharmacovigilance Product Specification
14.4.3 ICON plc Pharmacovigilance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Accenture Plc.
14.5.1 Accenture Plc. Company Profile
14.5.2 Accenture Plc. Pharmacovigilance Product Specification
14.5.3 Accenture Plc. Pharmacovigilance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Elsevier
14.6.1 Elsevier Company Profile
14.6.2 Elsevier Pharmacovigilance Product Specification
14.6.3 Elsevier Pharmacovigilance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 PRA Health Sciences, Inc.
14.7.1 PRA Health Sciences, Inc. Company Profile
14.7.2 PRA Health Sciences, Inc. Pharmacovigilance Product Specification
14.7.3 PRA Health Sciences, Inc. Pharmacovigilance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Mapi Group
14.8.1 Mapi Group Company Profile
14.8.2 Mapi Group Pharmacovigilance Product Specification
14.8.3 Mapi Group Pharmacovigilance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Atlantic Research Group
14.9.1 Atlantic Research Group Company Profile
14.9.2 Atlantic Research Group Pharmacovigilance Product Specification
14.9.3 Atlantic Research Group Pharmacovigilance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 GSK
14.10.1 GSK Company Profile
14.10.2 GSK Pharmacovigilance Product Specification
14.10.3 GSK Pharmacovigilance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Pharmacovigilance Market Forecast (2022-2027)
15.1 Global Pharmacovigilance Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Pharmacovigilance Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Pharmacovigilance Value and Growth Rate Forecast (2022-2027)
15.2 Global Pharmacovigilance Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Pharmacovigilance Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Pharmacovigilance Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Pharmacovigilance Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Pharmacovigilance Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Pharmacovigilance Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Pharmacovigilance Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Pharmacovigilance Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Pharmacovigilance Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Pharmacovigilance Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Pharmacovigilance Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Pharmacovigilance Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Pharmacovigilance Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Pharmacovigilance Consumption Forecast by Type (2022-2027)
15.3.2 Global Pharmacovigilance Revenue Forecast by Type (2022-2027)
15.3.3 Global Pharmacovigilance Price Forecast by Type (2022-2027)
15.4 Global Pharmacovigilance Consumption Volume Forecast by Application (2022-2027)
15.5 Pharmacovigilance Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
